Key publications

Use of vitamin K antagonists for secondary stroke prevention depends on the treating healthcare provider in Germany - results from the German AFNET registry.

Haeusler KG, Gerth A, Limbourg T, Tebbe U, Oeff M, Wegscheider K, Treszl A, Ravens U, Meinertz T, Kirchhof P, Breithardt G, Steinbeck G, Nabauer M; AFNET registry investigators.

BMC Neurol. 2015 Aug 5;15:129. doi: 10.1186/s12883-015-0371-8.


Morbidity and treatment in patients with atrial fibrillation and chronic kidney disease.

Reinecke H, Nabauer M, Gerth A, Limbourg T, Treszl A, Engelbertz C, Eckardt L, Kirchhof P, Wegscheider K, Ravens U, Meinertz T, Steinbeck G, Breithardt G; AFNET Study Group.

Kidney Int. 2015 Jan;87(1):200-9. doi: 10.1038/ki.2014.195. Epub 2014 Jun 4.


Impact of the type of centre on management of AF patients: surprising evidence for differences in antithrombotic therapy decisions.

Kirchhof P, Nabauer M, Gerth A, Limbourg T, Lewalter T, Goette A, Wegscheider K, Treszl A, Meinertz T, Oeff M, Ravens U, Breithardt G, Steinbeck G; AFNET registry investigators.

Thromb Haemost. 2011 Jun;105(6):1010-23. doi: 10.1160/TH11-02-0070. Epub 2011 May 5.


The Registry of the German Competence NETwork on Atrial Fibrillation: patient characteristics and initial management.

Nabauer M, Gerth A, Limbourg T, Schneider S, Oeff M, Kirchhof P, Goette A, Lewalter T, Ravens U, Meinertz T, Breithardt G, Steinbeck G.

Europace. 2009 Apr;11(4):423-34. doi: 10.1093/europace/eun369. Epub 2009 Jan 18.